These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3092393)
81. Red blood cell distribution width should indeed be assessed with other inflammatory markers in daily clinical practice. Ephrem G Cardiology; 2013; 124(1):61. PubMed ID: 23328401 [No Abstract] [Full Text] [Related]
82. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Blann AD; Porter M; McCollum CN Br Heart J; 1992 Dec; 68(6):635-6. PubMed ID: 1467064 [No Abstract] [Full Text] [Related]
83. Reply: To PMID 23553899. Ephrem G Clin Cardiol; 2013 Jun; 36(6):365. PubMed ID: 23657950 [No Abstract] [Full Text] [Related]
84. Kinetics of plasma von Willebrand factor in acute myocardial infarction patients: a meta-analysis. Wang X; Zhao J; Zhang Y; Xue X; Yin J; Liao L; Xu C; Hou Y; Yan S; Liu J Oncotarget; 2017 Oct; 8(52):90371-90379. PubMed ID: 29163836 [TBL] [Abstract][Full Text] [Related]
85. On the versatility of von Willebrand factor. Rauch A; Wohner N; Christophe OD; Denis CV; Susen S; Lenting PJ Mediterr J Hematol Infect Dis; 2013; 5(1):e2013046. PubMed ID: 23936617 [TBL] [Abstract][Full Text] [Related]
86. The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery. Matsuura K; Imamaki M; Ishida A; Shimura H; Miyazaki M Heart Vessels; 2009 May; 24(3):169-74. PubMed ID: 19466516 [TBL] [Abstract][Full Text] [Related]
87. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis]. Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633 [TBL] [Abstract][Full Text] [Related]
88. Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction. Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Tsoufis C; Marinou K; Charakida M; Stefanadi E; Vavuranakis M; Latsios G; Stefanadis C Int J Cardiol; 2007 Feb; 115(2):203-7. PubMed ID: 16787670 [TBL] [Abstract][Full Text] [Related]
89. [Variations of plasma Willebrand factor and fibrinogen in coronary pathology]. Wiesel ML; Mossard JM; Grunebaum L; Cazenave JP; Sacrez A Ann Biol Clin (Paris); 1992; 50(1):15-9. PubMed ID: 1443785 [TBL] [Abstract][Full Text] [Related]
90. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina. Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817 [TBL] [Abstract][Full Text] [Related]
91. The von Willebrand factor in myocardial infarction and unstable angina: a kinetic study. Margulis T; David M; Maor N; Soff GA; Grenadier E; Palant A; Aghai E Thromb Haemost; 1986 Jun; 55(3):366-8. PubMed ID: 3092393 [TBL] [Abstract][Full Text] [Related]
92. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
93. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease. Budde U; Metzner HJ; Müller HG Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573 [TBL] [Abstract][Full Text] [Related]
94. New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates. Menache D; Aronson DL Thromb Haemost; 1997 Jul; 78(1):566-70. PubMed ID: 9198217 [TBL] [Abstract][Full Text] [Related]